Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry
Abstract Alzheimer disease (AD) is a leading cause of dementia that has gained prominence in our aging society. Yet, the complexity of diagnosing AD and measuring its invasiveness poses an obstacle. To this end, blood-based biomarkers could mitigate the inconveniences that impede an accurate diagnos...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-05384-8 |